Share this post on:

Product Name :
RTX-134

Search keywords :
Phenylalanine ammonia-lyase

drugId :
null

Target Vo:
Phenylalanine ammonia-lyase

Target Vo Short Name :
Ava-3988

Moa_Name:
Phenylalanine ammonia-lyase replacements

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Rubius Therapeutics Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Phenylketonurias

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Anti-Mouse CD209b Antibody (22D1) Protocol
Mitazalimab Epigenetics
Phospho-AMPK alpha 2 (Thr172) Antibody: Phospho-AMPK alpha 2 (Thr172) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 62 kDa, targeting to Phospho-AMPK alpha 2 (Thr172). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.

Share this post on:

Author: Betaine hydrochloride